Requires medicaid and insurers to include coverage for testing of PFAS levels in blood; defines PFAS.

This bill requires Medicaid and private insurance companies in New York to cover the costs of testing for PFAS levels in people's blood. PFAS are harmful chemicals often found in various products and can pose health risks. The bill aims to ensure that individuals can access testing without financial barriers.

Supporters of the bill would highlight its importance in protecting public health by ensuring that New Yorkers can easily access critical testing for harmful PFAS chemicals. They would argue that this legislation is a necessary step toward addressing environmental health issues and promoting awareness of chemical exposure.

Critics might argue that the bill imposes additional costs on Medicaid and insurance providers, potentially leading to higher premiums for consumers. They may also question the necessity of widespread testing, suggesting that resources could be better allocated to more pressing health concerns.